Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
At Ulta Beauty (NASDAQ:ULTA), a filing with the SEC revealed that on Friday, Director Charles Heilbronn bought 127,889 shares of ULTA, for a cost of $195.21 each, for a total investment of $24.97M. Heilbronn was up about 3.5% on the buy at the high point of today's trading session, with ULTA trading as high as $202.02 at last check today. Ulta Beauty is trading up about 3.7% on the day Tuesday. This purchase marks the first one filed by Heilbronn in the past year.
And at Orthopediatrics Corporation (NASDAQ:KIDS), there was insider buying on Monday, by Director David R. Pelizzon who purchased 10,000 shares at a cost of $13.00 each, for a trade totaling $130,000. This buy marks the first one filed by Pelizzon in the past twelve months. Orthopediatrics Corporation is trading down about 0.4% on the day Tuesday. So far Pelizzon is in the green, up about 43.3% on their purchase based on today's trading high of $18.63.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.